SIMON NICHOLAS J III

10% owner at TERCICA INC · on record since Mar 16, 2004
Director at COTHERIX INC · on record since Jan 19, 2006
10% owner at COTHERIX INC · on record since Jan 19, 2006
10% owner at HELICOS BIOSCIENCES CORP · on record since May 31, 2007
Director at PONIARD PHARMACEUTICALS, INC. · on record since Apr 27, 2006
10% owner at PONIARD PHARMACEUTICALS, INC. · on record since Apr 27, 2006
10% owner at AFFYMAX INC · on record since Dec 21, 2006
10% owner at Pharmasset Inc · on record since Apr 26, 2007
10% owner at Pernix Sleep, Inc. · on record since May 10, 2007
Director at BARRIER THERAPEUTICS INC · on record since Jun 8, 2007
Director at ARYx Therapeutics, Inc. · on record since Nov 13, 2007
10% owner at ARYx Therapeutics, Inc. · on record since Nov 13, 2007
See explanation below at Altimmune, Inc. · on record since Aug 7, 2007
10% owner at Altimmune, Inc. · on record since Aug 7, 2007
10% owner at BARRIER THERAPEUTICS INC · on record since Apr 28, 2004
10% owner at ReShape Weightloss Inc. · on record since Nov 21, 2007
Director at RIGEL PHARMACEUTICALS INC · on record since Jul 8, 2003
10% owner at RIGEL PHARMACEUTICALS INC · on record since Jul 8, 2003
10% owner at · on record since Dec 22, 2009
Former 10% Owner at · on record since Dec 15, 2010
10% owner at · on record since May 19, 2011
Director at · on record since Oct 27, 2003
10% owner at · on record since Aug 10, 2012
Former 10% stockholder at · on record since Sep 29, 2016

Insider trading activity of SIMON NICHOLAS J III

Transactions on record: 125; since Nov 5, 2003

Open-market buys: 8; $23.9M

Open-market sells: 45; $62.3M

Companies traded: 12; last filing Apr 30, 2013

Figures computed from official regulatory filings — .

Companies where SIMON NICHOLAS J III has traded

3 tx · $7M · Apr 30, 2013
6 tx · Feb 7, 2013
2 tx · $1.3M · Jul 2, 2012
5 tx · $387.8K · Oct 6, 2011
7 tx · $8.6M · Nov 5, 2010
16 tx · $7M · Oct 4, 2010
9 tx · $9.7M · Jun 11, 2010
15 tx · $3M · Apr 2, 2008
6 tx · $10.7M · Jun 8, 2007
16 tx · $57.6M · Jan 10, 2007
37 tx · $47.9M · Jun 3, 2005
3 tx · Nov 14, 2003

Track record of SIMON NICHOLAS J III

Statistical track record

Free account

Open-market buys: 14

Last buy: Apr 23, 2013

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of SIMON NICHOLAS J III

Co-insiders of SIMON NICHOLAS J III

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Radius Health, Inc.Listing unverified	Apr 30, 2013	BuyD (derivative)	91,175	61.42 USD	$5.6M	ClusterFirst in 12mo	SEC
Radius Health, Inc.Listing unverified	Apr 30, 2013	BuyD (derivative)	227,939	6.14 USD	$1.4M	ClusterFirst in 12mo	SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	1,949,879	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	313,527	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-1,949,879	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-275,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-337,622	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	369,522	—	n/a (No price was disclosed in the filing)		SEC
Pernix Sleep, Inc.Listing unverified	Jul 2, 2012	Sell	-19,500	0.29 USD	$5.7K		SEC
Radius Health, Inc.Listing unverified	Nov 22, 2011	BuyD (derivative)	61,408	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-100,000	1.02 USD	$102K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-23,308	1.02 USD	$23.8K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-33,124	1.02 USD	$33.8K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-53,800	1.02 USD	$54.9K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-170,000	1.02 USD	$173.4K		SEC
Altimmune, Inc.Listing on record	Nov 5, 2010	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Altimmune, Inc.Listing on record	Nov 5, 2010	Buy	430,000	3.50 USD	$1.5M	conv 10	SEC
Altimmune, Inc.Listing on record	Nov 5, 2010	Other	2,428,171	2.54 USD	$6.2M	Unusual size	SEC
ARYx Therapeutics, Inc.Security delisted	Oct 4, 2010	BuyD (derivative)	500,000	0.01 USD	$5K	Cluster	SEC
ARYx Therapeutics, Inc.Security delisted	Aug 17, 2010	BuyD (derivative)	500,000	0.01	$5K	ClusterFirst in 12mo	SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Jun 11, 2010	Award	72,289	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARYx Therapeutics, Inc.Security delisted	May 3, 2010	AwardD (derivative)	6,666	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Nov 9, 2009	Sell	-264,648	8.06	$2.1M		SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Nov 9, 2009	Sell	-152,052	8.50	$1.3M		SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Nov 9, 2009	Sell	-78,262	8.00	$626.1K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Radius Health, Inc.Listing unverified	Apr 30, 2013	BuyD (derivative)	91,175	61.42 USD	$5.6M	ClusterFirst in 12mo	SEC
Radius Health, Inc.Listing unverified	Apr 30, 2013	BuyD (derivative)	227,939	6.14 USD	$1.4M	ClusterFirst in 12mo	SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	1,949,879	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	313,527	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-1,949,879	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-275,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-337,622	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	369,522	—	n/a (No price was disclosed in the filing)		SEC
Pernix Sleep, Inc.Listing unverified	Jul 2, 2012	Sell	-19,500	0.29 USD	$5.7K		SEC
Radius Health, Inc.Listing unverified	Nov 22, 2011	BuyD (derivative)	61,408	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-100,000	1.02 USD	$102K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-23,308	1.02 USD	$23.8K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-33,124	1.02 USD	$33.8K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-53,800	1.02 USD	$54.9K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 6, 2011	Sell	-170,000	1.02 USD	$173.4K		SEC
Altimmune, Inc.Listing on record	Nov 5, 2010	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Altimmune, Inc.Listing on record	Nov 5, 2010	Buy	430,000	3.50 USD	$1.5M	conv 10	SEC
Altimmune, Inc.Listing on record	Nov 5, 2010	Other	2,428,171	2.54 USD	$6.2M	Unusual size	SEC
ARYx Therapeutics, Inc.Security delisted	Oct 4, 2010	BuyD (derivative)	500,000	0.01 USD	$5K	Cluster	SEC
ARYx Therapeutics, Inc.Security delisted	Aug 17, 2010	BuyD (derivative)	500,000	0.01	$5K	ClusterFirst in 12mo	SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Jun 11, 2010	Award	72,289	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARYx Therapeutics, Inc.Security delisted	May 3, 2010	AwardD (derivative)	6,666	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Nov 9, 2009	Sell	-264,648	8.06	$2.1M		SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Nov 9, 2009	Sell	-152,052	8.50	$1.3M		SEC
PONIARD PHARMACEUTICALS, INC.Listing on record	Nov 9, 2009	Sell	-78,262	8.00	$626.1K		SEC